The Leukemia & Lymphoma Society - Rocky Mountain Chapter is honored to be the beneficiary of the 17th Annual Foundation at Rolling Hills Golf Classic. This beloved event features a golf tournament and Superhero-themed poolside gala that will celebrate the life of Rolling Hills member, Chris Pancoast.
Questions? Contact Aaron Dunn at aaron.dunn@lls.org.
_______________________________________________________________________
SCHEDULE
Saturday, June 25, 2016
Team Panky Poolside Gala from 6:00 - 9:00pm
Join us as we celebrate the life of Rolling Hills member, Chris Pancoast
Monday, June 27, 2016
Golf Tournament with two shotguns starts
- Morning Shotgun
7:00 – 8:00am check-in and breakfast
8:30am Shotgun start
Followed by award presentation and reception
- Afternoon Shotgun
12:00 – 1:00 pm check-in and buffet lunch
1:30 pm Shotgun start
Followed by award presentation and reception
_______________________________________________________________________
About The Foundation at Rolling Hills
The Foundation at Rolling Hills, founded in 1999, is a nonprofit organization with the mission of raising funds for the benefit of worthy charitable causes in the local Denver metro community. The Club at Rolling Hills is the only golf club in Colorado and one of only six in the United States with associated charitable foundations.
About the Golf Classic
With its strong commitment to the local community and through a stated mission of raising funds for the benefit of charitable causes in the local community, The Foundation at Rolling Hills has raised over $1.8 million through the Golf Classic for causes such as The Tennyson Center, The Second Wind Fund, Make a Wish Foundation and many others. Last year’s beneficiary was Young Americans Center. LLS is honored to be the beneficiary of the 2016 Golf Classic.
About The Leukemia & Lymphoma Society
LLS has invested more than $1 billion in research to advance blood cancer therapies and save lives but we will not be satisfied until we find a cure. Last year alone, LLS invested approximately $70 million in cutting-edge research and our work is not done. Join us in the fight for a cure today — register for a foursome today.
LLS's continued advancements over the years, are responsible for the blood cancer survival rate doubling and tripling; in some cases, the survival rate has even quadrupled. And many LLS supported therapies not only help blood cancer patients but are now used to treat patients with rare forms of stomach and skin cancers. They're even being tested in clinical trials for patients with a range of cancers including lung, brain, breast, pancreatic and prostate cancers. LLS funded drugs like Gleevec, Sprycel, Arinza, Tasigna and Zolinza are now being tested for patients with other non-cancerous diseases like Diabetes, Rheumatoid Arthritis and Multiple Sclerosis.
We really are changing the face of blood cancer!
For more information about LLS, please visit lls.org
